Package 68462-219-60

Brand: topiramate

Generic: topiramate
NDC Package

Package Facts

Identity

Package NDC 68462-219-60
Digits Only 6846221960
Product NDC 68462-219
Product ID 68462-219_d99570b6-84b2-4402-9d58-3e4da0f94370
Description

60 CAPSULE, COATED PELLETS in 1 BOTTLE (68462-219-60)

Marketing

Marketing Status
Marketed Since 2024-07-16
Brand topiramate
Generic topiramate
Sample Package No

Linked Drug Pages (1)

Topiramate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "d99570b6-84b2-4402-9d58-3e4da0f94370", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0368462218600", "0368462219607"], "unii": ["0H73WJJ391"], "rxcui": ["205315", "205316"], "spl_set_id": ["872927eb-0b61-44bb-9892-3c700b6f2181"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE, COATED PELLETS in 1 BOTTLE (68462-219-60)", "package_ndc": "68462-219-60", "marketing_start_date": "20240716"}], "brand_name": "Topiramate", "product_id": "68462-219_d99570b6-84b2-4402-9d58-3e4da0f94370", "dosage_form": "CAPSULE, COATED PELLETS", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68462-219", "generic_name": "Topiramate", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "25 mg/1"}], "application_number": "ANDA217869", "marketing_category": "ANDA", "marketing_start_date": "20240716", "listing_expiration_date": "20271231"}